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INTRODUCTION
In 1985, McCarty and colleagues reported a series of patients
characterized by symmetrical and acute synovitis, marked pit-
ting edema, the absence of rheumatoid factor (RF), increased
acute phase reactants, lack of bony erosions on radiography,
and benign and short clinical course (remitting seronegative
symmetric synovitis with pitting edema, RS3PE syndrome)
(1, 2). Since this original description, numerous additional
cases have been reported. Pitting edema, one of the main char-
acteristics of RS3PE, may also be noted in connective tissue
disorders, such as systemic sclerosis, polymyositis, and mixed
connective tissue disease (MCTD) (3). During the course of
Sjogren’s syndrome, 50% of all patients experience episodes
of arthritis. Articular symptoms and signs include arthralgia,
morning stiffness, intermittent synovitis and chronic poly-
arthritis (4). However, there has been no report of RS3PE in
Sjogren’s syndrome until now, and we herein describe the first
case of Sjogren’s syndrome presenting as RS3PE.
CASE REPORT
A 35-yr-old woman was admitted because of swelling in the
face and lower legs in April 2001. She had been healthy until
the previous December when she developed fever, swelling,
and pain in both knees, ankles, and wrist joints. Then the swel-
ling spread to her lower legs, feet, face, and hands. The swel-
ling was worse in the morning and after walking. She expe-
rienced intermittent pain in the knees, ankles, and wrists for
a few days. The morning stiffness lasted less than 30 min. She
was admitted to another hospital and was suspected to have
lupus or rheumatoid arthritis. In March 2001, she developed
dry mouth and underwent lower lip biopsy. Three days prior to
admission in April, the swelling in her face and lower legs was
aggravated. Her past medical history included artificial fer-
tilization in 1996, but she denied oral ulcer, photosensitivity,
alopecia, dry eye, or Raynaud’s phenomenon. She had expe-
rienced intermittent lumbar pain for the previous few years.
On physical examination, she had a puffy face but no swelling
or tenderness in the parotid gland. She had swelling and pit-
ting edema in her hands (Fig. 1A), lower legs, and the dorsum
of the feet (Fig. 1B), but there was no associated tenderness.
However, she did have swelling in both wrist and left 2nd
proximal interphalangeal joint and tenderness in both meta-
carpophalangeal joints and the right knee joint. There was no
tenderness in the lumbar spine or buttock. The straight leg
raising test was negative. Extremity muscle power was intact.
Laboratory tests gave a white cell count of 4,330/ L, hemo-
globin 11 g/dL, platelet 172,000/ L, Westergren erythrocyte
sedimentation rate 27 mm/hr (reference range 0-9), serum pro-
tein 5.9 g/dL, albumin 2.9 g/dL, aspartate aminotransferase/
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Sjogren's Syndrome Presenting as Remitting Seronegative
Symmetric Synovitis with Pitting Edema (RS3PE)
Remitting seronegative symmetric synovitis with pitting edema (RS3PE) syndrome
is characterized by symmetrical and acute synovitis, pitting edema, the absence
of rheumatoid factor, increased acute phase reactants, lack of bony erosions on
radiography, and benign and short clinical course. Half of all patients with Sjogren’s
syndrome experience arthritis during the disease course. We here describe the
first case of Sjogren’s syndrome presenting as RS3PE. She had swelling in knees,
ankles, and wrists. After then the swelling spread to her lower legs, feet, face, and
both hands. She was admitted to another hospital and was suspected of lupus or
rheumatoid arthritis. Three months later, she had dry mouth and had lower lip biop-
sy. She was admitted to this hospital due to development of swelling in face and
lower legs for 3 days. On physical examination, she had pitting edema in both hands
and feet dorsum. Laboratory test showed elevated erythrocyte sedimentation rate,
positivity of rheumatoid factor, anti-nuclear antibody, and anti-Ro antibody. There
was no erosion in the hands radiography. Schirmer’s test and lip biopsy was com-
patible with Sjogren’s syndrome. She was diagnosed RS3PE and Sjogren’s syn-
drome. She was begun with prednisolone and her symptoms improved gradually.
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alanine aminotransferase 27/13 IU/L (reference range <40/
<40), and creatinine 0.8 mg/dL. Urine analysis was normal.
Serologic tests indicated RF 54.4 IU/mL (reference range 10-
30), antinuclear antibody (ANA) 1:320 in a speckled pattern,
positive anti-Ro antibody, and weakly positive anti-ribonu-
cleoprotein (RNP) antibody. The tests were negative for anti-
La antibody, anti-ds DNA antibody, HLA-B7 and B27. Thy-
roid function test was normal. There were no abnormal radio-
graphy findings in the hands, lumbar spine and pelvis. Bone
scintigraphy revealed the absence of any active lesion of bone
or joint. Minor salivary gland biopsy showed moderate lym-
phocytes infiltration and two foci of more than 50 lympho-
cytes infiltration (Fig. 2). The result of Schirmer’s test was
compatible with Sjogren’s syndrome (<5/5 min in both eyes).
Therefore, the patient was diagnosed with Sjogren’s syndrome
presenting as RS3PE and she was given prednisolone at 20
mg/day. Her symptoms showed gradual improvement and
5 months after discharge, the prednisolone treatment was
tapered to 10 mg/day.
DISCUSSION
The present case exhibited the characteristic features of the
RS3PE syndrome: acute symmetrical polysynovitis with pit-
ting edema of the dorsum of the hands and feet and negative
radiologic finding. However, the presence of RS3PE syndrome
is rare in young woman and its association with rheumatoid
factor positivity is also uncommon. Although the presence of
HLA-B7 has been noted in 9-75% of RS3PE cases (5, 6), HLA-
B7 was negative in the present case. We suspect that the pres-
ence of autoantibodies such as ANA and RF is a systemic au-
toimmune process of Sjogren’s syndrome. Because her arthri-
tis was not present for at least 6 weeks and morning stiffness
did not last for at least 1 hr before maximal improvement, she
was not satisfied with the criteria for the classification of rhe-
umatoid arthritis. Differential diagnoses in this patient includ-
ed spondyloarthropathies (7, 8), systemic sclerosis, mixed con-
nective tissue disease (MCTD), and systemic lupus erythemato-
sus (3). She did not complain of inflammatory back pain. Her
pelvis AP radiography and bone scintigraphy showed normal
findings. Although she presented hands edema and anti-RNP
antibody, which might suggest MCTD, she did not exhibit
myositis, Raynaud’s phenomenon, or acrosclerosis. The titer
of anti-RNP antibody was low for the criteria of MCTD. The
patient did not have clinical features of lupus, except ANA
positivity. In Sjogren’s syndrome, 50% of patients experience
A B
Fig. 1. Swelling and pitting edema of both hands (A) and the dorsum of the feet (B).
Fig. 2. Minor salivary gland biopsy showing moderate lymphocytes
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episodes of arthritis during the disease course. Articular symp-
toms and signs include arthralgia, morning stiffness, intermit-
tent synovitis, and chronic polyarthritis. Joint radiography of
the hands usually do not reveal erosive changes (4, 9). There
has been no previously published report of RS3PE in a patient
with Sjogren’s syndrome. Many authors have reported that
RS3PE appears to be an early manifestation of rheumatic dis-
eases because the underlying diseases sometimes require sev-
eral years to manifest and need to be followed for a long time
(10, 11). In the present case, RS3PE might have occurred inci-
dentally or as an early manifestation of Sjogren’s syndrome.
In summary, we herein described the first case of Sjogren’s
syndrome presenting as RS3PE. It is suggested that the pos-
sibility of Sjogren’s syndrome should be taken into consider-
ation for the differential diagnosis of patients with RS3PE.
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